Fernando Herz Wolff

Fernando Herz Wolff

Auto-generated profile, based on publicly available information

Fernando Herz Wolff

Porto Alegre, RS, Brasil. Hospital Moinhos de Vento Unidade de Endoscopia Porto Alegre RS Brasil

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
MMManuel Mendizabal
Manuel Mendizabal
FPFederico Piñero
Federico Piñero
Ezequiel RidruejoEzequiel Ridruejo
Ezequiel Ridruejo
FWFernando Herz Wolff
Fernando Herz Wolff
MAMargarita Anders
Margarita Anders
MSMarcelo Silva
Marcelo Silva

1 September 2010 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
NCNelson Cheinquer
Nelson Cheinquer
HCHugo Cheinquer
Hugo Cheinquer
FWFernando H. Wolff
Fernando H. Wolff
SCSilvia Coelho-Borges
Silvia Coelho-Borges
Background and objectivesEvidence suggests that sustained virologic response to interferon treatment decreases incidence of hepatocellular carcinoma in patients with hepatitis C virus cirrhosis. This study was designed to compare the incidence of hepatocellular carcinoma among cirrhotic patients exposed to interferon based treatment with or without achieving a sustained virological response, in order to evaluate the role of interferon itself in the prevention hepatocellular carcinoma.MethodsA cohort of 85 patients with compensated hepatitis C cirrhosis was followed after treatment with interferon and ribavirin. Sustained virological response was defined as negative polymerase chain reaction assay 24 weeks after the end of treatment. Patients were followed every 6 months with ultrasound and alpha-fetoprotein. Hepatocellular carcinoma was diagnosed by the finding of a focal liver lesion greater than 2 cm with arterial hypervascularization on two imaging techniques and/or by liver biopsy.ResultsThe mean follow-up time was 32.1 ± 20 months for patients who achieved a sustained virological response and 28.2 ± 18 months among 47 patients (55%) without SVR. Hepatocellular carcinoma was diagnosed in 1 (3%) vs. 8 (17%) responders and non responders respectively (p = 0.02).ConclusionPatients with cirrhosis due to hepatitis C virus who achieved sustained virological response had significantly lower incidence of hepatocellular carcinoma when compared to those without treatment response. Interferon treatment without achieving sustained virological response does not seem to protect against hepatocellular carcinoma

1 June 2008 in Digestive and Liver Disease
Verified
Journal Article
Closed access
FWF.H. Wolff
F.H. Wolff
SFSandra Fuchs
Sandra Fuchs
NBN.T. Barcellos
N.T. Barcellos
MFM. Falavigna
M. Falavigna
MCM. Cohen
M. Cohen
FFFlávio Danni Fuchs
Flávio Danni Fuchs

29 November 2012 in Hepatology
Verified
Journal Article
Open access
PDF file
CCCatiane Tiecher Cusinato
Catiane Tiecher Cusinato
AKAna Paula Messa Koetz
Ana Paula Messa Koetz
NBNêmora Tregnago Barcellos
Nêmora Tregnago Barcellos
FWFernando Herz Wolff
Fernando Herz Wolff
Click on the article title to read more.

24 January 2007
Verified
Reference Entry
Closed access
MFMaicon Falavigna
Maicon Falavigna
CKChristian Kieling
Christian Kieling
FWFernando H Wolff
Fernando H Wolff
LMLídia Rf Medeiros
Lídia Rf Medeiros
HCHugo Cheinquer
Hugo Cheinquer

1 January 2025 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
CRCarolina Roos Mariano DA Rocha
Carolina Roos Mariano DA Rocha
SBSophia Andreola Borba
Sophia Andreola Borba
TRThales Tomaz Richinho
Thales Tomaz Richinho
LGLeonardo Wagner Grillo
Leonardo Wagner Grillo
FSFernando Comunello Schacher
Fernando Comunello Schacher
FSFabio Segal
Fabio Segal
BACKGROUND/OBJECTIVE: Colonoscopy is a known tool for diagnosing precursor lesions of colorectal cancer. The use of AI has the potential to enhance the detection of these lesions. The aim of this study is to compare the adenoma detection rate (ADR) in colonoscopies performed with and without AI software.